Bryan Newman
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Advanced Drug Delivery Systems 9
- Drug Solubulity and Delivery Systems 8
- Advancements in Transdermal Drug Delivery 7
-
- Inhalation and Respiratory Drug Delivery 14
- Co-authors
- Hasan Körkaya (3 shared papers)Max S. Wicha (2 shared papers)Shawn G. Clouthier (2 shared papers)Duxin Sun (6 shared papers)Sarah J. Conley (2 shared papers)Amber Heath (1 shared paper)Yanke Yu (2 shared papers)Yanyan Li (2 shared papers)
- Journals
- International Journal of Pharmaceutics (6 papers)Pharmaceutical Research (4 papers)Clinical Pharmacology & Therapeutics (2 papers)The AAPS Journal (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Bryan Newman
31 papers receiving 1.7k citations
Bryan Newman's Hit Papers
Peers
Comparison fields: 5 of 116
- Pharmaceutical Science 249
- Cancer Research 387
- Complementary and alternative medicine 175
- Oncology 557
- Toxicology 47
Countries citing papers authored by Bryan Newman
This map shows the geographic impact of Bryan Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Newman more than expected).
Fields of papers citing papers by Bryan Newman
This network shows the impact of papers produced by Bryan Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Newman. The network helps show where Bryan Newman may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Newman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia Hit paper breakdown → | 2012 | 521 |
| 2 | 2010 | 443 | |
| 3 | 2009 | 250 | |
| 4 | 2016 | 69 | |
| 5 | 2018 | 58 | |
| 6 | 2012 | 57 | |
| 7 | 2015 | 54 | |
| 8 | 2017 | 37 | |
| 9 | 2017 | 34 | |
| 10 | 2012 | 27 | |
| 11 | 2016 | 23 | |
| 12 | 2017 | 22 | |
| 13 | 2020 | 20 | |
| 14 | 2018 | 20 | |
| 15 | 2022 | 18 | |
| 16 | 2017 | 15 | |
| 17 | 2022 | 12 | |
| 18 | 2010 | 12 | |
| 19 | 2022 | 11 | |
| 20 | 2022 | 11 |
About Bryan Newman
Bryan Newman is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine, Physiology, Molecular Biology and Oncology, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (14 papers), Advanced Drug Delivery Systems (9 papers), Drug Solubulity and Delivery Systems (8 papers), Asthma and respiratory diseases (7 papers), Advancements in Transdermal Drug Delivery (7 papers), Dermatology and Skin Diseases (3 papers), Cancer Cells and Metastasis (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Pharmaceutical Science (249 citations), Cancer Research (387 citations), Complementary and alternative medicine (175 citations), Oncology (557 citations) and Toxicology (47 citations). Bryan Newman has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Hasan Körkaya, Max S. Wicha, Shawn G. Clouthier, Duxin Sun, Sarah J. Conley, Amber Heath, Yanke Yu, Yanyan Li, Steven J. Schwartz and Tao Zhang. Their work appears in journals such as International Journal of Pharmaceutics, Pharmaceutical Research, Clinical Pharmacology & Therapeutics, The AAPS Journal and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.